US Patent 8398976 Antibodies to EGFL7 and methods for their use

Patent 8398976 was granted and assigned to Genentech on March, 2013 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Genentech

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8398976

Patent Inventor Names

Jo-Anne Hongo0

Yan Wu0

Weilan Ye0

Maike Schmidt0

Date of Patent

March 19, 2013

Patent Application Number

13087247

Date Filed

April 14, 2011

Patent Citations Received

‌

US Patent 11702469 Recombinant EGFL7, EGFL7 antibodies, and uses thereof

Patent Primary Examiner

‌

Sheela J. Huff

Patent abstract

The invention provides anti-EGFL7 antibodies, and compositions comprising and methods of using these antibodies.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8398976 Antibodies to EGFL7 and methods for their use

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API